Poly(ADP-Ribose) Polymerase Inhibition Improves Erectile Function in Diabetic Rats

Journal of Sexual Medicine

Volumn 8, Issue 4, 2011, Pages 1002-1014

  Wan, Zhihua H ^a   Li, Wenzhou Z ^a   Li, Yunzhu Z ^a   Chen, Lin ^a   Li, Guohao H ^a   Hu, Weifeng F ^a   Peng, Song ^a   Yu, Jiajun J ^a   Guo, Feng ^a  

^a CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

Corpus Cavernosa; Diabetes Mellitus; Diabetic Neurovascualr Dysfunction; Erectile Dysfunction; Poly(ADP ribose) Polymerase; Rat

Indexed keywords

N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PENIS ERECTION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

EID: 79953324138     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01963.x     Document Type: Article

References (46)

1. Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep 2002;2:501-9.
2. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999;281:421-6.
3. Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802-13.
4. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75:191-236.
5. Burnett AL, Musicki B. The nitric oxide signaling pathway in the penis. Curr Pharm Des 2005;11:3987-94.
6. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl 2006;27:335-47.
7. Butler AR, Flitney FW, Williams DL. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: A chemist's perspective. Trends Pharmacol Sci 1995;16:18-22.
8. Darley-Usmar V, White R. Disruption of vascular signalling by the reaction of nitric oxide with superoxide: Implication for cardiovascular disease. Exp Physiol 1997;82:305-16.
9. Papaharalambus CA, Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 2007;17:48-54. [PubMed: 17292046].
10. Khan MA, Thompson CS, Mumtaz FH, Mikhailidis DP, Morgan RJ, Bruckdorfer RK, Naseem KM. The effect of nitric oxide and peroxynitrite on rabbit cavernosal smooth muscle relaxation. World J Urol 2001;19:220-4.
11. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999;6:347-63.
12. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL. High glucose induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002;16:1738-48.
13. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium derived contracting factor. Am J Physiol 1989;257(1 Pt 2):H33-7.
14. Szabó C. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol Res 2005;52:60-71.
15. de Murcia G, Ménissier de Murcia J. Poly(ADP-ribose) polymerase: A molecular nick-sensor. Trends Biochem Sci 1994;19:172-6.
16. Garcia Soriano F, Virág L, Jagtap P, Szabó E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabó C. Diabetic endothelial dysfunction: The role of poly (ADP-ribose) polymerase activation. Nat Med 2001;7:108-13.
17. Pieper AA, Walles T, Wei G, Clements EE, Verma A, Snyder SH, Zweier JL. Myocardial postischemic injury is reduced by poly(ADP-ribose)polymerase-1 gene disruption. Mol Med 2000;6:271-82.
18. Zheng L, Szabo C, Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53:2960-7.
19. Patel S, Santani D. Role of NF-kappaB in the pathogenesis of diabetes and its associated complications. Pharmacol Rep 2009;61:595-603.
20. Keegan A, Cotter MA, Cameron NE. Effects of diabetes and treatment with the antioxidant, α-lipoic acid, on endothelial and neurogenic functions of corpus cavernosum in rats. Diabetologia 1999;42:343-50.
21. Gibson TM, Cotter MA, Cameron NE. Effects of poly(ADP- ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats. Nitric Oxide 2006;15:344-50.
22. Kendirci M, Zsengellér Z, Bivalacqua TJ, Gur S, Usta MF, Chen M, Szabó C, Hellstrom WJ. Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury. J Urol 2005;174:2054-9.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
24. Champion HC, Bivalacqua TJ, Hyman AL, Ignarro LJ, Hellstrom WJ, Kadowitz PJ. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA 1999;96:11648-52.
25. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: The relation is revisited. Diabetes 2005;54:3435-41.
26. Virág L, Szabó C. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 2001;15:99-107.
27. Shukla N, Jones R, Persad R, Angelini GD, Jeremy JY. Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol 2005;517:224-31.
28. phox NAD[P]H oxidase induced by the thromboxane a2 mimetic, u46619, in corpus cavernosal smooth muscle cells. BJU Int 2005;96:423-7.
29. Teixeira CE, Priviero FB, Webb RC. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1h-pyrazolo[3, 4-b]pyridine-3-yl]pyrimidin-4-ylamine (bay 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice. J Pharmacol Exp Ther 2007;322:1093-102.
30. Jin L, Lagoda G, Leite R, Webb RC, Burnett AL. NADPH oxidase activation: A mechanism of hypertension-associated erectile dysfunction. J Sex Med 2008;5:544-51.
31. Rotrosen D, Leto TL. Phosphorylation of neutrophil 47-kda cytosolic oxidase factor. Translocation to membrane is associated with distinct phosphorylation events. J Biol Chem 1990;265:19910-5.
32. Nangle MR, Cotter MA, Cameron NE. IkappaB kinase 2 inhibition corrects defective nitrergic erectile mechanisms in diabetic mouse corpus cavernosum. Urology 2006;68:214-8.
33. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. J Urol 2002;168(4 Pt 1):1332-6.
34. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter doubleblind placebo-controlled fixed-dose study. Diabetes Care 2003;26:777-83.
35. Angulo J, González-Corrochano R, Cuevas P, Fernández A, La Fuente JM, Rolo F, Allona A, Sáenz de Tejada I. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries. J Sex Med 2010;7(2 Pt 1):758-68.
36. Saenz de Tejada I, Goldstein I, Azadzoi KM, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-30.
37. Bivalacqua TJ, Usta MF, Champion HC, Adams D, Namara DB, Abdel-Mageed AB, Kadowitz PJ, Hellstrom WJ. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003;169:1911-7.
38. El-Sakka AI, Lin CS, Chui RM, Dahiya R, Lue TF. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res 1999;11:123-32.
39. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C. 1997 Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997;50:1016-26.
40. Podlasek CA, Zelner DJ, Bervig TR, Gonzalez CM, McKenna KE, McVary KT. Characterization and localization of nitric oxide synthase isoforms in the BB/WOR diabetic rat. J Urol 2001;166:746-55.
41. Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem 2007;14:1729-38.
42. De Young L, Yu D, Bateman RM, Brock GB. Oxidative stress and antioxidant therapy: Their impact in diabetes-associated erectile dysfunction. J Androl 2004;25:830-6.
43. Yamanaka M, Shirai M, Shiina H, Shirai M, Tanaka Y, Fujime M, Okuyama A, Dahiya R. Loss of anti-apoptotic genes in aging ratncrura. J Urol 2002;168:2296-300.
44. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats. J Urol 2003;170:291-7.
45. Li WJ, Park K, Paick JS, Kim SW. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats. J Sex Med 2010; Mar 2 [Epub ahead of print] doi: 10.1111/j.1743-6109.2010.01724.x.
46. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003;52:2353-62.